ω- carboxy aryl substituted diphenyl ureas as RAF kinase inhibitors

2000 
(57) Abstract: The present invention includes the use of aryl ureas group in the treatment of raf-mediated disease, to pharmaceutical compositions for use in such therapies.
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []